Massive Bio Company
Massive Bio is an AI powered oncology platform that connects patients to clinical trials while enabling pharma to get access to patients.
Investors
Founded Date:
2015-05-04
Total Funding:
137650394
Investor Type:
support@massivebio.com
Employee Number:
11-50
Funding Status:
Early Stage Venture
Technology:
['BioTech & HealthTech']
Last Funding Type:
Venture - Series Unknown
Investors Number:
13.0
Last Funding Date:
2022-06-02
Industry:
Medical BioTech
Headquarters:
New York, New York, United States
Estimated Revenue:
$1M to $10M